AU2022296214A1 - Heterocycloalkyl-substituted polyheteroazole derivative as medical drug for treatment and/or prevention of rs virus infectious disease - Google Patents
Heterocycloalkyl-substituted polyheteroazole derivative as medical drug for treatment and/or prevention of rs virus infectious disease Download PDFInfo
- Publication number
- AU2022296214A1 AU2022296214A1 AU2022296214A AU2022296214A AU2022296214A1 AU 2022296214 A1 AU2022296214 A1 AU 2022296214A1 AU 2022296214 A AU2022296214 A AU 2022296214A AU 2022296214 A AU2022296214 A AU 2022296214A AU 2022296214 A1 AU2022296214 A1 AU 2022296214A1
- Authority
- AU
- Australia
- Prior art keywords
- optionally substituted
- chem
- aryl
- mmol
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021106034 | 2021-06-25 | ||
| JP2021-106034 | 2021-06-25 | ||
| PCT/JP2022/025361 WO2022270628A1 (ja) | 2021-06-25 | 2022-06-24 | Ｒｓウイルス感染症の処置および／または予防用医薬としてのヘテロシクロアルキル置換ポリヘテロアゾール誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2022296214A1 true AU2022296214A1 (en) | 2024-01-25 |
Family
ID=84545504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2022296214A Pending AU2022296214A1 (en) | 2021-06-25 | 2022-06-24 | Heterocycloalkyl-substituted polyheteroazole derivative as medical drug for treatment and/or prevention of rs virus infectious disease |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240327392A1 (https=) |
| EP (1) | EP4361148A4 (https=) |
| JP (1) | JPWO2022270628A1 (https=) |
| CN (1) | CN117730079A (https=) |
| AU (1) | AU2022296214A1 (https=) |
| CA (1) | CA3223875A1 (https=) |
| WO (1) | WO2022270628A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025206404A1 (ja) * | 2024-03-29 | 2025-10-02 | 国立大学法人 大分大学 | 線維症治療のための抗線維化化合物 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL140040A0 (en) * | 1998-06-03 | 2002-02-10 | Guilford Pharm Inc | N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres |
| DOP2000000107A (es) * | 1999-12-01 | 2002-09-16 | Agouron Pharmaceutical Inc | Compuestos, composiciones y metodos para estimular el crecimiento y alongamiento de las neuronas |
| US6589978B2 (en) * | 2000-06-30 | 2003-07-08 | Hoffman-La Roche Inc. | 1-sulfonyl pyrrolidine derivatives |
| JP4221989B2 (ja) * | 2002-09-30 | 2009-02-12 | 大正製薬株式会社 | オキサジアゾール誘導体 |
| JP4240978B2 (ja) * | 2002-09-30 | 2009-03-18 | 大正製薬株式会社 | アリールオキシメチルオキサジアゾール誘導体 |
| JP2006523669A (ja) * | 2003-03-10 | 2006-10-19 | ファイザー・インク | Ｎｉｍａ調節タンパク質（ｐｉｎ１）を阻害するための、リン酸／硫酸エステル化合物および医薬組成物 |
| EP1604989A1 (en) * | 2004-06-08 | 2005-12-14 | Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft | DPP-IV inhibitors |
| EP1981845A2 (en) * | 2006-02-08 | 2008-10-22 | Wyeth | Sulfonamide derivatives to treat infection with hepatitis c virus |
| MX2012007420A (es) * | 2009-12-24 | 2012-07-23 | Vertex Pharma | Analogos para el tratamiento o prevencion de infecciones de flavivirus. |
| CN102869657A (zh) * | 2010-03-24 | 2013-01-09 | 沃泰克斯药物股份有限公司 | 用于治疗或预防黄病毒感染的类似物 |
| JP6122868B2 (ja) * | 2011-12-22 | 2017-04-26 | ギリアード サイエンシーズ， インコーポレイテッド | 抗ウイルス剤としてのピラゾロ［１，５−ａ］ピリミジン |
| JP2016504284A (ja) * | 2012-11-16 | 2016-02-12 | バイオクリスト ファーマスーティカルズ，インコーポレイテッドＢｉｏｃｒｙｓｔ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． | 抗ウイルス性アザ糖を含有するヌクレオシド |
| US9637516B2 (en) * | 2012-12-31 | 2017-05-02 | Hetero Research Foundation | Betulinic acid proline derivatives as HIV inhibitors |
| US20170129916A1 (en) * | 2014-06-26 | 2017-05-11 | Hetero Research Foundation | Novel betulinic proline imidazole derivatives as hiv inhibitors |
| WO2015198263A2 (en) * | 2014-06-26 | 2015-12-30 | Hetero Research Foundation | Novel betulinic proline substituted derivatives as hiv inhibitors |
| WO2016091774A1 (en) * | 2014-12-08 | 2016-06-16 | Janssen Sciences Ireland Uc | Piperidine substituted pyrazolo[1,5-a]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (rsv) |
| WO2018051254A1 (en) * | 2016-09-14 | 2018-03-22 | Aurigene Discovery Technologies Limited | Cyclic substituted-1,2,4-oxadiazole compounds as immunomodulators |
| WO2018051255A1 (en) * | 2016-09-14 | 2018-03-22 | Aurigene Discovery Technologies Limited | Cyclic substituted-1,3,4-oxadiazole and thiadiazole compounds as immunomodulators |
| JP6862305B2 (ja) | 2017-07-13 | 2021-04-21 | 株式会社マキタ | 衣服及び報知システム |
| RU2712097C1 (ru) * | 2018-09-28 | 2020-01-24 | Общество с ограниченной ответственностью "Необиотек" | Ингибитор дипептидилпептидазы-4 для лечения сахарного диабета 2-го типа, соединения (варианты) |
| JP7684282B2 (ja) * | 2020-03-31 | 2025-05-27 | 田辺三菱製薬株式会社 | ヒドロキシピロリジン誘導体およびその医薬用途 |
-
2022
- 2022-06-24 US US18/573,760 patent/US20240327392A1/en active Pending
- 2022-06-24 CA CA3223875A patent/CA3223875A1/en active Pending
- 2022-06-24 EP EP22828544.1A patent/EP4361148A4/en active Pending
- 2022-06-24 CN CN202280044481.9A patent/CN117730079A/zh active Pending
- 2022-06-24 AU AU2022296214A patent/AU2022296214A1/en active Pending
- 2022-06-24 JP JP2023530145A patent/JPWO2022270628A1/ja active Pending
- 2022-06-24 WO PCT/JP2022/025361 patent/WO2022270628A1/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP4361148A1 (en) | 2024-05-01 |
| EP4361148A4 (en) | 2025-07-09 |
| CA3223875A1 (en) | 2022-12-29 |
| JPWO2022270628A1 (https=) | 2022-12-29 |
| WO2022270628A1 (ja) | 2022-12-29 |
| US20240327392A1 (en) | 2024-10-03 |
| CN117730079A (zh) | 2024-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2020213376B2 (en) | Compounds and methods for the targeted degradation of the androgen receptor | |
| KR102506324B1 (ko) | 알파 v 인테그린 억제제로서의 시클로부탄- 및 아제티딘-함유 모노 및 스피로시클릭 화합물 | |
| AU2018260844B2 (en) | Processes of making and crystalline forms of a MDM2 inhibitor | |
| EP2981536B1 (en) | N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b | |
| AU2002219555B2 (en) | VLA-4 Inhibitors | |
| JP6142919B2 (ja) | 血栓塞栓症の治療のための第ＸＩａ因子阻害剤としての置換ピロリジン | |
| CN106255679B (zh) | 用作nav通道抑制剂的杂环化合物及其用途 | |
| AU2016371014A1 (en) | Polycyclic TLR7/8 antagonists and use thereof in the treatment of immune disorders | |
| KR20050037973A (ko) | 디펩티딜 펩티데이즈-ⅳ(ｄｐｐ-ⅳ) 저해용 신규 화합물,그것의 제조방법 및 그것을 활성성분으로서 함유하는 약제조성물 | |
| JP6337750B2 (ja) | 化合物 | |
| JP7564528B2 (ja) | 狂犬病の治療のための化合物およびその方法 | |
| CA3167361C (en) | 1,3,4-OXADIAZOLE DERIVATIVES USED AS HISTONE DEACETYLASE 6 INHIBITORS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | |
| JP2025528804A (ja) | イソインドリン置換グルタルイミド骨格に基づく化合物、及びその応用 | |
| JPH0820597A (ja) | トロンビン阻害作用を有する複素環カルボニル化合物 | |
| CA3196061A1 (en) | Cftr modulator compounds, compositions, and uses thereof | |
| TW202540125A (zh) | 雙環雜芳基化合物 | |
| CN111606970B (zh) | 一种1，5-二氮杂双环[5,3,0]十烷酮氨基酸衍生物及其制备方法和应用 | |
| AU2022296214A1 (en) | Heterocycloalkyl-substituted polyheteroazole derivative as medical drug for treatment and/or prevention of rs virus infectious disease | |
| EP1757602A1 (en) | Vla-4 inhibitor | |
| CN114685601B (zh) | 雄性激素受体结合分子及其用途 | |
| CN102753166A (zh) | 四肽类似物及其制备和应用 | |
| WO2025146502A1 (en) | Coronavirus inhibiting compounds | |
| WO2025206404A1 (ja) | 線維症治療のための抗線維化化合物 | |
| OA20440A (en) | Nitrile-containing antiviral compounds | |
| HK40053743A (en) | Compound for treatment of rabies and method for treatment of rabies |